ALA 6.06% 17.5¢ arovella therapeutics limited

So now what?, page-3

  1. 5,758 Posts.
    lightbulb Created with Sketch. 809
    Except the problem is, maybe they can't give you more.

    They already know it I think. Artimist is dead. The rest of the suite is simply like having a travel agent to travel. They help you get there a little quicker, on the shortest route. But if you had to pay for that service, would you think twice?

    They can't get deals across the line because it doesn't work well enough or Pharma simply sees no value in it.
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.